Terms: = Lung cancer AND MALT1, ENSG00000172175, 10892 AND Treatment
9 results:
1. Profiling the activity of the para-caspase malt1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
[TBL] [Abstract] [Full Text] [Related]
2. malt1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.
Saba NS; Wong DH; Tanios G; Iyer JR; Lobelle-Rich P; Dadashian EL; Liu D; Fontan L; Flemington EK; Nichols CM; Underbayev C; Safah H; Melnick A; Wiestner A; Herman SEM
Cancer Res; 2017 Dec; 77(24):7038-7048. PubMed ID: 28993409
[TBL] [Abstract] [Full Text] [Related]
3. Update in primary pulmonary lymphomas.
Cardenas-Garcia J; Talwar A; Shah R; Fein A
Curr Opin Pulm Med; 2015 Jul; 21(4):333-7. PubMed ID: 25978630
[TBL] [Abstract] [Full Text] [Related]
4. An Unusual Presentation of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma as Diffuse Pulmonary Infiltrates with Spontaneous Regression.
Kang HS; Lee HY; Kim SJ; Kim SC; Kim YK; Park GS; Lee KY; Jung JI; Kang JY
Cancer Res Treat; 2015 Oct; 47(4):943-8. PubMed ID: 25381826
[TBL] [Abstract] [Full Text] [Related]
5. [Pulmonary malt lymphoma].
Borie R; Antoine M; Cadranel J; Wislez M
Bull Cancer; 2014 Feb; 101(2):195-202. PubMed ID: 24509230
[TBL] [Abstract] [Full Text] [Related]
6. [High incidence of t (11; 18)/API2-malt1 and BCL10 aberrant nuclear expression in pulmonary mucosa-associated lymphoid tissue lymphomas].
Li BZ; Yang WT; Lu HF; Fan YZ; Zhou XY; Shi DR
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):831-5. PubMed ID: 19080537
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-malt1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract] [Full Text] [Related]
8. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract] [Full Text] [Related]
9. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract] [Full Text] [Related]
